Anomalous Antimicrobial Susceptibility Trend Identification

by Levy CIMAR | Aug 27, 2020 | Publications

Morphological profiling of tubercle bacilli identifies drug pathways of action

by Levy CIMAR | Aug 4, 2020 | Publications

Renal impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data from Two Randomized Clinical Trials

by Levy CIMAR | Jun 26, 2020 | Publications

Iyob Gebremariam, Levy CIMAR Software Developer

by Levy CIMAR | Jun 9, 2020 | Trainees

Urban Informal Settlements as Hotspots of Antimicrobial Resistance and the Need to Curb Environmental Transmission

by Levy CIMAR | May 25, 2020 | Publications